Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) dropped 17.1% during trading on Wednesday . The stock traded as low as GBX 2.80 and last traded at GBX 2.90. Approximately 8,095,493 shares changed hands during trading, an increase of 469% from the average session volume of 1,422,115 shares. The stock had previously closed at GBX 3.50.
Cizzle Biotechnology Price Performance
The stock has a market cap of £12.32 million, a P/E ratio of -17.06 and a beta of 0.02. The business’s fifty day moving average price is GBX 2.77 and its 200 day moving average price is GBX 2.04.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The company reported GBX (0.17) earnings per share (EPS) for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Featured Articles
- Five stocks we like better than Cizzle Biotechnology
- Buyback Capacity Is Rising Across 3 Soaring and Sinking Stocks
- How to Invest in the Biggest European Defense Surge in Decades
- The Netflix-Lionsgate Rumor Exposed a Bigger Shift in Media M&A
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
